Merck Healthcare
Improving patient lives through innovation
- B2B
- Has physical offices
- Manufacturing
- Sales-led purchase
About Merck Healthcare
The company is dedicated to advancing cancer treatment, improving care for chronic diseases, and helping couples achieve their dream of having a baby through innovative therapies and technologies
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001–10,000 employees
- Headquarters
- Darmstadt, Hessen, Germany
- Founded
- 1668
- Revenue
- $131M – $1BTamtam estimate
- Website
- merckgroup.com
Jobs at Merck Healthcare
- Expert GHO Controlling Excellence Center (all genders)
- Medical Representative (CDO)
- Apprentisage - Technologue en production biotechnologique CFC (h/f/d)
- Clinical Site Management Excellence Lead (all genders)
- Site Production Manager (Chemical / Pharmaceutical Manufacturing) (f/m)
- Pharmacovigilance Scientist, Global Patient Safety Japan_ Biopharma
- IT Product Owner Global Value, Access and Pricing
- Head of Data Standards & CRF Design (all genders)
Merck Healthcare in the news
- Merck inks $2.13B deal for experimental cancer drug
Merck acquired global rights to SciBrunch Therapeutics' experimental cancer drug, SPR2015, for up to $2.13 billion to target the KRAS G12D mutation in various cancers.
- Merck (NYSE:MRK) Hits Cholesterol Pipeline Milestone
Merck's oral cholesterol candidate achieved its primary and key secondary goals in a pivotal study, marking a significant step in its cardiovascular pipeline and offering a potential oral alternative to injectable treatments.
- Merck (NYSE:MRK) Wins Welireg Approval and Licenses Oral KRAS Drug
Merck secured FDA approval for Welireg in advanced renal cell carcinoma, licensed an oral KRAS inhibitor, and withdrew a lung cancer drug application.
- What Is Driving the Latest Milestones at Merck & Co. (NYSE:MRK)?
Merck & Co. achieved multiple regulatory milestones in oncology, including a Japanese clearance for a subcutaneous formulation and a positive European opinion for a bladder cancer regimen, during a period of market caution.
- Why Is Merck (NYSE:MRK) in the Spotlight as Market Breadth Diverges Around AI Strength?
Merck is focusing on new drug development and acquisitions to prepare for Keytruda's patent expiration, navigating market shifts and healthcare policy changes.
Merck Healthcare at a glance
Merck Healthcare is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Darmstadt, Hessen, Germany.
Merck Healthcare was founded in 1668.
Merck Healthcare has 5,001–10,000 employees.
Merck Healthcare's revenue is $131M – $1B (Tamtam estimate).
Merck Healthcare is hiring: 8 recent open roles, including Expert GHO Controlling Excellence Center (all genders), Medical Representative (CDO), Apprentisage - Technologue en production biotechnologique CFC (h/f/d).
Selling to companies like Merck Healthcare?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies